Literature DB >> 7872799

Novel extracellular matrix-associated serine proteinase inhibitors from human skin fibroblasts.

C N Rao1, Y Y Liu, C L Peavey, D T Woodley.   

Abstract

Serine proteinase inhibitors play a major role in the turnover of connective tissues. In this study, we isolated and determined partial amino-terminal amino acid sequence of trypsin/elastase/plasmin inhibitors (M(r) 33,000 and 31,000) from the extracellular matrix of SV40-transformed human skin fibroblasts. The antitrypsin activity of the inhibitors was monitored by substrate reverse zymography. Polyclonal antisera to alpha 1-antitrypsin, alpha 1-antichymotrypsin, alpha 2-antiplasmin, inter-alpha-trypsin inhibitor, plasminogen activator inhibitors-1 and -2, and a monoclonal antibody to protease nexin-1 did not label the 33-, 31-, and 27-kDa inhibitors. A computer search for amino acid sequence homology indicated that the 31-kDa inhibitor is novel. In contrast, the sequence of the 33-kDa inhibitor shared 70 to 90% homology with the amino-terminal sequence of a recently characterized 32-kDa trypsin/tissue factor inhibitor called tissue factor pathway inhibitor-2. The 33- and 31-kDa inhibitors bind to heparin-Sepharose and were recovered from the affinity beads as well as from the t12 FB extracellular matrix with 1 M NaCl. Based on these results, we propose that the extracellular matrix of human mesenchymal cells sequester a family of novel serine proteinase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7872799     DOI: 10.1006/abbi.1995.1168

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  20 in total

1.  Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion.

Authors:  S D Konduri; A Tasiou; N Chandrasekar; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis.

Authors:  Kanagasabai Vadivel; Sathya-Moorthy Ponnuraj; Yogesh Kumar; Anne K Zaiss; Matthew W Bunce; Rodney M Camire; Ling Wu; Denis Evseenko; Harvey R Herschman; Madhu S Bajaj; S Paul Bajaj
Journal:  J Biol Chem       Date:  2014-09-28       Impact factor: 5.157

3.  Methylation of TFPI-2 is an early event of esophageal carcinogenesis.

Authors:  Yan Jia; Yunsheng Yang; Malcolm V Brock; Baoping Cao; Qimin Zhan; Yazhuo Li; Yuanzi Yu; James G Herman; Mingzhou Guo
Journal:  Epigenomics       Date:  2012-04       Impact factor: 4.778

4.  In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2.

Authors:  S S Lakka; S D Konduri; S Mohanam; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line.

Authors:  Shakuntala Kondraganti; Christopher S Gondi; Meena Gujrati; Ian McCutcheon; Dzung H Dinh; Jasti S Rao; William C Olivero
Journal:  Int J Oncol       Date:  2006-07       Impact factor: 5.650

Review 6.  DNA methylation in hepatocellular carcinoma.

Authors:  Iris Tischoff; Andrea Tannapfe
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

7.  Protective effects of recombinant kunitz-domain 1 of human tissue factor pathway inhibitor-2 against 2-chloroethyl ethyl sulfide toxicity in vitro.

Authors:  Moonsuk S Choi; Kalpana Parikh; Ashima Saxena; Nageswararao Chilukuri
Journal:  Eplasty       Date:  2007-12-03

8.  Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion.

Authors:  Sophie Iochmann; Claire Bléchet; Valérie Chabot; Annabelle Saulnier; Aniça Amini; Guillaume Gaud; Yves Gruel; Pascale Reverdiau
Journal:  Clin Exp Metastasis       Date:  2009-03-07       Impact factor: 5.150

9.  Detection of TFPI2 methylation in the serum of hepatocellular carcinoma patients.

Authors:  Feng-Kai Sun; Yu-Chen Fan; Jing Zhao; Feng Zhang; Shuai Gao; Ze-Hua Zhao; Qi Sun; Kai Wang
Journal:  Dig Dis Sci       Date:  2012-10-31       Impact factor: 3.199

10.  A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.

Authors:  Offer Erez; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Francesca Gotsch; Juan Pedro Kusanovic; Nandor Gabor Than; Shali Mazaki-Tovi; Edi Vaisbuch; Zoltan Papp; Bo Hyun Yoon; Yu Mi Han; Debra Hoppensteadt; Jawed Fareed; Sonia S Hassan; Roberto Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.